Asia Pacific Direct-to-Consumer Genetic Testing Market Forecast to 2030
Asia Pacific Direct-to-Consumer Genetic Testing Market Forecast to 2030 – Regional Analysis – by Test Type (Ancestry Testing, Predictive Testing, Nutrigenomics Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), and Distribution Channel (Online and Offline)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the Asia Pacific Direct-to-Consumer Genetic Testing Market
There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.
SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.
Asia Pacific Direct-to-Consumer Genetic Testing Market Overview
The Asia Pacific direct-to-consumer genetic testing market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the fastest pace among all major regions in the world during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.
Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation
The Asia Pacific direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.
Based on test type, the Asia Pacific direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.
In terms of technology, the Asia Pacific direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.
Based on distribution channel, the Asia Pacific direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.
Based on country, the Asia Pacific direct-to-consumer genetic testing market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific direct-to-consumer genetic testing market in 2022.
Genesis Healthcare Co, Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Asia Pacific direct-to-consumer genetic testing market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Asia Pacific direct-to-consumer genetic testing market was valued at US$ 354.24 in 2022 and is expected to reach US$ 1,530.84 million by 2030, registering a CAGR of 20.1% from 2022 to 2030. Increasing awareness about potential benefits of genetic testing and growing adoption of Single Nucleotide polymorphism (SNP) chips are among the critical factors attributed to the Asia Pacific direct-to-consumer genetic testing market expansion.
Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing is steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs. Direct-to-consumer genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders. The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and advances in genome sequencing technology have enabled rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. Direct-to-consumer genetic testing has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. Thus, the growing awareness among the population regarding genetic testing drives the Asia Pacific direct-to-consumer genetic testing market.
On the contrary, high cost and privacy concerns associated with direct-to-consumer genetic testing hamper the growth Asia Pacific direct-to-consumer genetic testing market .
Based on test type, the Asia Pacific direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing segment held 64.3% share of the Asia Pacific direct-to-consumer genetic testing market in 2022, amassing US$ 227.74 million. It is projected to garner US$ 954.18 million by 2030 to expand at 19.6% CAGR during 2022-2030.
By technology, the Asia Pacific direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held 68.6% share of Asia Pacific direct-to-consumer genetic testing market in 2022, amassing US$ 243.18 million. It is projected to garner US$ 1,079.06 million by 2030 to expand at 20.5% CAGR during 2022-2030.
Based on distribution channel, the Asia Pacific direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held 65.7% share of Asia Pacific direct-to-consumer genetic testing market in 2022, amassing US$ 232.64 million. It is projected to garner US$ 1,018.14 million by 2030 to expand at 20.3% CAGR during 2022-2030.
Based on country, the Asia Pacific direct-to-consumer genetic testing market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 27.4% share of Asia Pacific direct-to-consumer genetic testing market in 2022, amassing US$ 97.00 million. It is projected to garner US$ 432.79 million by 2030 to expand at 20.6% CAGR during 2022-2030.
Key players operating in the Asia Pacific direct-to-consumer genetic testing market are Genesis Healthcare Co, Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd, among others.
– In September 2023; 23andMe Holding Co. and the Sickle Cell 101, have joined forces to expand awareness of people’s sickle cell carrier status. The collaboration will include DNA testing and access to 23andMe’s Health + Ancestry Service for up to 1,000 eligible participants, and 23andMe will be providing monetary support to Sickle Cell 101 to support this effort.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific direct-to-consumer genetic testing market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific direct-to-consumer genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Direct-to-Consumer Genetic Testing Market Landscape
4.1 Overview
5. Asia Pacific Direct-to-Consumer Genetic Testing Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Incidence of Genetic Disorders
5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
5.2 Market Restraints
5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
5.3 Market Opportunities
5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
5.4 Future Trends
5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
5.5 Impact Analysis
6. Direct-to-Consumer Genetic Testing Market – Asia Pacific Market Analysis
6.1 Overview
6.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Ancestry Testing
7.3.1 Overview
7.3.2 Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Nutrigenomics Testing
7.4.1 Overview
7.4.2 Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Predictive Testing
7.5.1 Overview
7.5.2 Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Carrier Testing
7.6.1 Overview
7.6.2 Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Whole Genome Sequencing
8.3.1 Overview
8.3.2 Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Single Nucleotide Polymorphism Chips
8.4.1 Overview
8.4.2 Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Targeted Analysis
8.5.1 Overview
8.5.2 Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Online Platform
9.3.1 Overview
9.3.2 Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Offline Platform
9.4.1 Overview
9.4.2 Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
10.1.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.1.1.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.2.3 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
10.1.1.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.4 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.4.2 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.4.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
10.1.1.5 India: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.6 India: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.6.2 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.6.3 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
10.1.1.7 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.8 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.8.1 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.8.2 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.8.3 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
10.1.1.9 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.10 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.10.1 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.10.2 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.10.3 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
10.1.1.11 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.1.12 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.12.1 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.12.2 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
10.1.1.12.3 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
11. Asia Pacific Direct-to-Consumer Genetic Testing Market-Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Genesis Healthcare Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ancestry Genomics Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Myriad Genetics, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Living DNA Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 23andMe Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Genetic Technologies Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation
Table 2. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 5. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
Table 8. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 11. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 13. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Asia Pacific Direct-to-Consumer Genetic Testing Market
LIST OF FIGURES
Figure 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation, By Country
Figure 2. Asia Pacific Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
Figure 3. Asia Pacific Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 6. Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 12. Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 17. Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 20. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 21. China: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. India: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Asia Pacific Direct-to-Consumer Genetic Testing Market
1. Genesis Healthcare Co
2. Ancestry Genomics Inc
3. Myriad Genetics, Inc.
4. Living DNA Ltd
5. 23andMe Inc
6. Genetic Technologies Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.